|
Effect of a synbiotic on functional abdominal pain in childhood
|
Azade Gholizadeh    , Sanaz Mehrabani , Mohammadreza Esmaeili Dooki , Mahmood Haji Ahmadi |
| Non-Communicable Pediatric Diseases Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran , mehrabanisanaz@gmail.com |
|
|
Abstract: (3149 Views) |
Background: One of the common functional gastrointestinal disorders in children is functional abdominal pain (FAP). The aim of the present study was to determine whether the administration of a synbiotic composed of fructo-oligosaccharides (FOS) and the seven types of beneficial bacteria is useful in FAP of childhood.
Methods: In this placebo-controlled, double-blind trial, 4-15-year-old children who met the Rome III criteria for FAP were randomly divided to receive either synbiotic or placebo twice daily for 4 weeks. Primary outcome was at least 50% reduction in the number of pain episodes, and secondary outcomes were a decline of at least two scales in the pain duration and intensity based on Wong-Baker scale. Response to therapy was decrease of pain frequency/intensity.
Results: A total of 67 children completed the trial (35 with synbiotic). Response rate was higher with synbiotic than placebo after four weeks (53.1 vs 11.4%; p<0.001), and synbiotic had significant superiority to placebo to relieve the duration (4.56±9.12 vs12±18.59, min/day, P=0.04), frequency (0.31±0.53vs 1.17±0.7, episode/Wk., P<.001) and intensity (2.38±2.29 vs 5.49±1.83, p<0.001) of abdominal pain.
Conclusion: Synbiotic compared to placebo significantly decreased the intensity, frequency and duration of FAP in children. |
|
| Keywords: Abdominal pain, Child, Synbiotic. |
|
|
Full-Text [PDF 226 kb]
(681 Downloads)
|
Type of Study: Original Article |
Subject:
Gastroentrology
Received: 2020/03/18 | Accepted: 2020/08/1 | Published: 2021/03/30
|
|
|
|
|
|
